News Overview



Amzell acquires early-stage drug or combination product (drug-device) candidates and repurposed drugs and develops them through proof of concept to registration for sale to commercial healthcare companies.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.